Edition:
United States

People: Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

5.19USD
23 May 2018
Change (% chg)

$-0.12 (-2.26%)
Prev Close
$5.31
Open
$5.44
Day's High
$5.44
Day's Low
$5.09
Volume
134,096
Avg. Vol
121,078
52-wk High
$7.30
52-wk Low
$1.86

Cherry, Joel 

Dr. Joel Cherry, Ph.D., is President - Research and Development of Amyris, Inc., since July 2011. He previously served as Senior Vice President of Research Programs and Operations since November 2008. Before joining Amyris, Dr. Cherry was Senior Director of Bioenergy Biotechnology at Novozymes, a biotechnology company focusing on development and manufacture of industrial enzymes from 1992 to November 2008. At Novozymes, he served in a variety of R&D scientific and management positions, including membership in Novozymes’ International R&D Management team, and as Principal Investigator and Director of the BioEnergy Project, a U.S. Department of Energy-funded $18 million effort initiated in 2000. Dr. Cherry holds a Bachelor of Arts degree in Chemistry from Carleton College and a Doctor of Philosophy degree in Biochemistry from the University of New Hampshire.

Basic Compensation

Total Annual Compensation, USD 358,750
Restricted Stock Awards, USD 322,920
Long-Term Incentive Plans, USD --
All Other, USD 322,000
Fiscal Year Total, USD 1,003,670

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --